# P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer

> **NCT01267357** · — · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 62 (actual)

## Conditions studied

- Serous Papillary Endometrial Cancer

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT01267357
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-11
- **Final completion:** —
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2010-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267357, "P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01267357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*